Pharmalot has been crunching the numbers for R&D jobs and concludes that the U.S. is seeing a considerable amount of shrinkage in the field. Looking at new numbers from PhRMA for 2006, R&D employment [1]Â among its members dropped 3.9 percent. And there were a number of sizable reductions last year, with the axe expected to drop again over the course of 2008.
RPM concludes that the biggest cutbacks in R&D are occurring in the approval and post-marketing phases. The money spent on R&D in the U.S. continues to rise, but after an 11.3 percent hike in 2006 budgets rose only 2.7 percent to a still considerable $35.4 billion.
- read the report [2] from Pharmalot
- see the PhRMA report [3]Â (.pdf)
Related Articles:
Top 8 layoffs [1] of 2007
The Top 15 R&D Budgets [4]
Big Pharma's biotech shift means layoffs for chemists [5]
Ranks of sales reps [6] thinning
Links:
[1] http://www.fiercebiotech.com/special-reports/top-5-layoffs-2007
[2] http://www.pharmalot.com/2008/04/where-the-jobs-arent-research-development/
[3] http://www.phrma.org/files/2008%20Profile.pdf
[4] http://www.fiercebiotech.com/special-reports/top-15-r-d-budgets
[5] http://www.fiercebiotech.com/story/big-pharma-s-biotech-shift-means-layoffs-chemists/2007-12-11
[6] http://www.fiercepharma.com/story/ranks-of-sales-reps-thinning/2008-03-18